hotspot -WSS

hotspot

author：knowledge 2025-09-06 02:06:48 - browse：26

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Wayne Brady comes out as pansexual: 'Free to love whomever I want'

WSS

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Idaho abortion case may prompt more restrictions in other states

Wegovy trial has doctors encouraged over new possibilities

Designating disabled people as health disparity population is crucial

The SUPPORT Act is critical to fighting the opioid crisis

Biotech reporter’s notebook: A sunnier mood at JPM 2024

hotspot

hotspot

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Idaho abortion case may prompt more restrictions in other states

23andMe had bad news about my health. I wish a person had delivered it

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Medicare details structure of new drug price negotiation program

FDA panel issues narrow recommendation for Covid vaccine booster doses

Novavax promises a turnaround & Lilly roils the obesity market

Designating disabled people as health disparity population is crucial

Cancer drug shortages should be causing more outrage

Why failed clinical trials don’t always spell doom for a new drug

hotspot

American woman, child freed after being kidnapped in Haiti last month

Biotech reporter’s notebook: A sunnier mood at JPM 2024

New menopause drug shows promise in relief for hot flashes

In same hospitals, Black patients receive fewer opioids than white patients

Methadone doses haven’t kept up in the age of fentanyl

Biotech reporter’s notebook: A sunnier mood at JPM 2024

explore

hotspot

explore

leisure time